Home | Contact For a local representative 1-877-633-2367
Test Image 1
Test Image 1
Test Image 1

Company Information

Medafor, Inc. develops and markets an innovative breakthrough in hemostatic technology and absorbable hemostats called Microporous Polysaccharide Hemospheres (MPH®). Based in Minneapolis, Minnesota, Medafor’s management and employees have significant experience working in the highly regulated global medical device and biotech community.

About Arista®AH

Microporous Polysaccharide Hemospheres (MPH®) rapidly dehydrate blood and accelerate the body’s natural blood clotting process. The MPH Technology is marketed worldwide under the brand name Arista®AH.

Mechanism of Action

News at Medafor | View All

January 24, 2012
Notice to Shareholders

October 13, 2011
Medafor Recognized as One of Minneapolis' Fastest-Growing Private Companies by Minneapolis/St. Paul Business Journal

July 8, 2011
Medafor Gets Approval to Use Arista®AH for Neurological Surgical Procedures in Canada

Upcoming Events | View All

STS 48th Annual Meeting
January 30 – February 1, 2012
Fort Lauderdale, FL

ACOG Annual Clinical Meeting 2012
May 5-9, 2012
San Diego, CA

Arista® AH Hemostatic Particles MPH Technology
Video Content will go here.